SyncThink’s EYE-SYNC Named Best New Technology Solution for Monitoring by MedTech Breakthrough Awards

June 6, 2018—Palo Alto, CA—SyncThink, a leader in neurotechnology and brain health analytics with foundational IP in eye tracking, had its EYE-SYNC technology named by MedTech Breakthrough as the best new technology solution for monitoring in its 2018 MedTech Breakthrough Awards program. The EYE-SYNC technology is an eye tracking solution currently used by top organizations such as the Golden State Warriors and Pac-12 Conference for monitoring fatigue and eye tracking impairments often associated with head injuries.

This year SyncThink has already also signed on the University of Georgia, Georgia Tech, announced a round of funding, brought on a seasoned Silicon Valley CEO, and obtained another patent to add to its every-growing IP. The Company anticipates continued growth throughout the rest of the year.

“We’re honored that EYE-SYNC and the work we are doing have received this recognition which underscores the importance of bringing objective brain health monitoring to athletes and patients” stated Laura Yecies, CEO   

The MedTech Breakthrough Awards program showcases technologies and companies that drive innovation and exemplify the best in medical and health related technology solutions around the globe. The SyncThink nomination was evaluated by an independent panel of experts within the MedTech industry, with winning products being assessed based on innovation, design, user-experience, as well as overall technological advancement for their respective categories.

For more information on the SyncThink EYE-SYNC technology, please visit www.syncthink.com

 

About SyncThink: SyncThink develops revolutionary eye-tracking technology analytics, now in VR headsets, that give medical professionals objective metrics for visual attention and dynamic orientation. Based on 15 years of research and 12 granted patents, SyncThink’s first product, EYE-SYNC, is a 60-second, objective sideline assessment that uses eye tracking to evaluate for ocular motor impairments and ocular vestibular dysfunction. FDA-cleared for detecting eye-tracking impairment, EYE-SYNC is used by leading university athletic departments and medical clinics, from Stanford University to Massachusetts General Hospital, SyncThink is transforming brain health assessment, recovery, and monitoring. www.syncthink.com